Clinical trial

Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After…

NCT00293631 · POZEN, Industry · Completed

Key facts

NCT number NCT00293631
Title Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
Official title A Randomized, Parallel-Group, Double-Blind, Single-Dose Study Evaluating the Efficacy and Safety of Intravenous Lornoxicam (8 mg and 16 mg) Compared to Intravenous Placebo and Ketorolac 30 mg in Management of Acute Postoperative Pain Following Orthopedic Surgery (Bunionectomy).
Lead sponsor POZEN, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Bunionectomy, Orthopedic Surgery
Intervention type Drug
Interventions Lornoxicam 8 mg, Lornoxicam 16 mg, Ketorolac 30 mg, Placebo
Enrollment 100
Start date Nov 1, 2005
Primary completion Mar 1, 2006
Completion Mar 1, 2006
First posted Feb 17, 2006
Last update posted Dec 3, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies